Paige

Paige delivers FDA-approved AI applications and a cloud-based platform to transform cancer diagnostics and biomarker discovery in digital pathology.

Paige is a leader in computational pathology, leveraging AI to enhance cancer diagnosis. Their core offering is The Paige Platform, featuring the FullFocus® viewer and a suite of AI applications like Paige Prostate and Paige Breast AI (including LN and biomarker tools). Notably, Paige was the first company to receive FDA approval for a clinical AI application in digital pathology, validating its technology. The platform is built on an industry-leading dataset (millions of slides from over 1,000 global institutions), ensuring high accuracy and generalizability. They recently introduced Paige Alba™ (an AI co-pilot) and were acquired by Tempus, solidifying their position in AI-enabled precision medicine.

https://paige.ai